InterCure Ltd. (TLV:INCR)
534.00
-11.50 (-2.11%)
Sep 4, 2025, 5:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 255.81 million as of September 5, 2025. Its market cap has decreased by -23.48% in one year.
Market Cap
255.81M
Enterprise Value
389.27M
Revenue
238.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
534.00
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 255.81M, an increase of 3,891.60%. That is a compound annual growth rate of 28.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 4, 2025 | 255.81M | -5.87% |
Dec 31, 2024 | 271.76M | 28.77% |
Dec 31, 2023 | 211.05M | -61.66% |
Dec 29, 2022 | 550.52M | -40.95% |
Dec 30, 2021 | 932.28M | 111.63% |
Dec 31, 2020 | 440.52M | 9.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 72.88B |
Danel (Adir Yeoshua) | 2.75B |
Kamada | 1.37B |
Bait Bakfar | 1.04B |
BrainsWay | 972.31M |
SofWave Medical | 937.79M |
Novolog (Pharm-Up 1966) | 752.01M |
Ilex Medical | 671.96M |